Jump Financial, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 5 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Jump Financial, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$452,008
-80.7%
14,295
-78.7%
0.02%
-86.3%
Q4 2022$2,344,329
+402.0%
67,192
+704.5%
0.12%
+588.9%
Q3 2022$467,000
-87.5%
8,352
-88.5%
0.02%
-88.9%
Q2 2022$3,747,000
+15.7%
72,400
+62.5%
0.16%
+16.5%
Q1 2022$3,238,000
+155.4%
44,554
+315.5%
0.14%
+73.8%
Q4 2021$1,268,000
-19.9%
10,723
-9.1%
0.08%
-29.8%
Q3 2021$1,583,000
+438.4%
11,800
+118.5%
0.11%
+128.0%
Q4 2020$294,0005,4000.05%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders